Five years ago, President Trump delivered a historic victory for American patients when he signed the No Surprises Act (NSA) into law. The promise of this...
In recent years, a growing outcry has drawn long-overdue attention to a difficult truth: girls’ and women’s pain has too often been dismissed and undertreated in...
LONDON — Novartis said Friday it was buying an experimental breast cancer drug from Delaware-based Synnovation Therapeutics for $2 billion upfront. The deal includes includes up...
Hundreds of individualized treatments for rare diseases could become available over the next decade — but only if government regulators handle the new therapeutics properly. At...
A U.S. district judge in Oregon said he will vacate a declaration made late last year by health secretary Robert F. Kennedy Jr. that asserted gender-affirming...